193 related articles for article (PubMed ID: 24626869)
1. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
[TBL] [Abstract][Full Text] [Related]
2. Possible options for new pertussis vaccines.
Meade BD; Plotkin SA; Locht C
J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
[TBL] [Abstract][Full Text] [Related]
3. Changing pertussis epidemiology: everything old is new again.
Clark TA
J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
[TBL] [Abstract][Full Text] [Related]
4. Licensed pertussis vaccines in the United States. History and current state.
Klein NP
Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
[TBL] [Abstract][Full Text] [Related]
5. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
Burns DL; Meade BD; Messionnier NE
J Infect Dis; 2014 Apr; 209 Suppl 1():S32-5. PubMed ID: 24626870
[No Abstract] [Full Text] [Related]
6. Pertussis: pertussis control strategies and the options for improving current vaccines.
Plotkin SA
Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
[TBL] [Abstract][Full Text] [Related]
7. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
8. Development of improved vaccines against whooping cough: current status.
Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
[TBL] [Abstract][Full Text] [Related]
9. Pertussis control: time for something new?
Clark TA; Messonnier NE; Hadler SC
Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
[TBL] [Abstract][Full Text] [Related]
10. Re-emergence of pertussis: what are the solutions?
Libster R; Edwards KM
Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
[TBL] [Abstract][Full Text] [Related]
11. Acellular pertussis vaccines: what lies ahead?
Wiedermann BL
Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
[TBL] [Abstract][Full Text] [Related]
12. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
[TBL] [Abstract][Full Text] [Related]
13. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
Moraga-Llop FA; Campins-Martà M
Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
[TBL] [Abstract][Full Text] [Related]
14. Nonhuman primate and human challenge models of pertussis.
Merkel TJ; Halperin SA
J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S20-3. PubMed ID: 24626867
[TBL] [Abstract][Full Text] [Related]
15. Public health. The pertussis paradox.
Allen A
Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
[No Abstract] [Full Text] [Related]
16. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.
Pesco P; Bergero P; Fabricius G; Hozbor D
Epidemics; 2014 Jun; 7():13-21. PubMed ID: 24928665
[TBL] [Abstract][Full Text] [Related]
17. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
18. The United States research strategy on pertussis.
La Montagne JR
Dev Biol Stand; 1997; 89():25-8. PubMed ID: 9272332
[TBL] [Abstract][Full Text] [Related]
19. Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.
Skoff TH; Baumbach J; Cieslak PR
Emerg Infect Dis; 2015 Sep; 21(9):1568-73. PubMed ID: 26291475
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
